{"title":"Offspring metabolic programming via the maternal diet increases susceptibility to metabolic dysregulation.","authors":"Xuguang Li, Nobuaki Shiraki, Takami Watanabe, Rikako Fukui, Kyohei Furukawa, Yusuke Kato, Yuri Nakahara, Shoen Kume, Akashi Taguchi, Youichiro Wada, Dwina Juliana Warman, Kenji Saito, Haruyo Nakajima-Adachi, Satoshi Hachimura, Hisanori Kato, Huijuan Jia","doi":"10.1016/j.ebiom.2025.105817","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Maternal nutrition during critical developmental windows is crucial for offspring metabolic programming. Methionine, an essential amino acid, is crucial in pancreatic differentiation. However, the impact of a maternal methionine-deficiency (MD) diet on offspring during the critical stage of embryonic pancreatic differentiation remains unclear.</p><p><strong>Methods: </strong>We used an in vitro human induced pluripotent stem cell (hiPSC) differentiation model and in vivo mouse and rat models to assess the impact of short-term maternal MD during pancreatic development. Offspring metabolic outcomes were evaluated under control or high-fat diet conditions. Multi-omics analyses were performed to explore mechanistic pathways, and Ruminococcus flavefaciens supplementation was used to assess microbiota-metabolite-host interactions.</p><p><strong>Findings: </strong>During foetal pancreatic development in mice, a two-day maternal MD diet induced long-term metabolic perturbations in offspring. MD disrupted pancreatic progenitor differentiation in vitro and altered offspring glucose homeostasis, pancreatic function, and gut microbiota composition in vivo. Male offspring showed impaired glucose tolerance, enhanced pancreatic differentiation, and increased susceptibility to diet-induced obesity in adulthood. These metabolic impairments were evident early in life, with MD neonates displaying altered metabolic profiles and pancreatic gene expression. We identified an association between maternal MD diet, gut microbiota-dependent R. flavefaciens abundance, and elevated creatine levels in both mothers and offspring. R. flavefaciens supplementation in mice recapitulates the observed metabolic dysregulation.</p><p><strong>Interpretation: </strong>Short-term maternal MD during foetal pancreatic development can induce lasting metabolic reprogramming in offspring. Gut microbiota-dependent creatine dysregulation may serve as a key mediator linking maternal diet to offspring metabolic susceptibility. These findings highlight the developmental impact of transient maternal nutrient imbalance and role of the microbiota-metabolite axis in shaping offspring health.</p><p><strong>Funding: </strong>See Acknowledgements.</p>","PeriodicalId":11494,"journal":{"name":"EBioMedicine","volume":"118 ","pages":"105817"},"PeriodicalIF":9.7000,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EBioMedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ebiom.2025.105817","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Maternal nutrition during critical developmental windows is crucial for offspring metabolic programming. Methionine, an essential amino acid, is crucial in pancreatic differentiation. However, the impact of a maternal methionine-deficiency (MD) diet on offspring during the critical stage of embryonic pancreatic differentiation remains unclear.
Methods: We used an in vitro human induced pluripotent stem cell (hiPSC) differentiation model and in vivo mouse and rat models to assess the impact of short-term maternal MD during pancreatic development. Offspring metabolic outcomes were evaluated under control or high-fat diet conditions. Multi-omics analyses were performed to explore mechanistic pathways, and Ruminococcus flavefaciens supplementation was used to assess microbiota-metabolite-host interactions.
Findings: During foetal pancreatic development in mice, a two-day maternal MD diet induced long-term metabolic perturbations in offspring. MD disrupted pancreatic progenitor differentiation in vitro and altered offspring glucose homeostasis, pancreatic function, and gut microbiota composition in vivo. Male offspring showed impaired glucose tolerance, enhanced pancreatic differentiation, and increased susceptibility to diet-induced obesity in adulthood. These metabolic impairments were evident early in life, with MD neonates displaying altered metabolic profiles and pancreatic gene expression. We identified an association between maternal MD diet, gut microbiota-dependent R. flavefaciens abundance, and elevated creatine levels in both mothers and offspring. R. flavefaciens supplementation in mice recapitulates the observed metabolic dysregulation.
Interpretation: Short-term maternal MD during foetal pancreatic development can induce lasting metabolic reprogramming in offspring. Gut microbiota-dependent creatine dysregulation may serve as a key mediator linking maternal diet to offspring metabolic susceptibility. These findings highlight the developmental impact of transient maternal nutrient imbalance and role of the microbiota-metabolite axis in shaping offspring health.
EBioMedicineBiochemistry, Genetics and Molecular Biology-General Biochemistry,Genetics and Molecular Biology
CiteScore
17.70
自引率
0.90%
发文量
579
审稿时长
5 weeks
期刊介绍:
eBioMedicine is a comprehensive biomedical research journal that covers a wide range of studies that are relevant to human health. Our focus is on original research that explores the fundamental factors influencing human health and disease, including the discovery of new therapeutic targets and treatments, the identification of biomarkers and diagnostic tools, and the investigation and modification of disease pathways and mechanisms. We welcome studies from any biomedical discipline that contribute to our understanding of disease and aim to improve human health.